REGULATION OF FAS-MEDIATED APOPTOSIS IN B CELLS
REGULATION OF FAS-MEDIATED APOPTOSIS IN B CELLS
批准号:
2457884
负责人:
THOMAS L ROTHSTEIN
金额:
$25.26万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1996
资助国家:
美国
项目状态:
已结题
起止时间:
1996-08-01 至 1999-07-31
关键词:
B lymphocyte CD antigens T lymphocyte anergy antiantibody apoptosis autoantibody autoimmunity biological signal transduction cell mediated lymphocytolysis test ceramides endopeptidases enzyme activity gene expression genetically modified animals interleukin 4 laboratory mouse lymphokines phosphorylation protein biosynthesis protein kinase C tyrosine western blottings
中文摘要
描述(改编自申请人的摘要):B细胞无能是一种
清除自身反应性免疫球蛋白特异性的机制。
无能B细胞在抗原受体减弱的状态下存活
反应性,并被T诱导的Fas介导的细胞凋亡所删除
效应细胞。正常B细胞对Fas诱导的细胞死亡的敏感性
可由IL-4R和SIG信号调节,从而产生一种状态
Fas耐药。指导这项研究的假设是无能B细胞
作为特定免疫信号的结果,可能会对
Fas介导的细胞凋亡,从而避免消除和呈现
随后激活和产生自身抗体的可能性。元素
这一假设对B细胞免疫能力和
一般情况下对细胞凋亡的调控。出于这个原因,而且因为如此之少
已知触发Fas耐药的方式,以及
已建立,建议探索对Fas定向细胞的保护
死亡分为3个阶段。1)评估IL-4对抗Fas介导的能力
通过抗Ig诱导细胞凋亡,并确定其他T细胞来源的作用
淋巴因子,使用标准的细胞毒性分析。2)确定新陈代谢
IL-4和IL-4对Fas介导的细胞凋亡产生抵抗的水平
通过检测Fas触发的蛋白酪氨酸事件,通过抗Ig
磷酸化、神经酰胺生产和蛋白水解酶激活
印迹、放射性标记脂类的鉴定和酶分析
蛋白质消化,并通过基因和蛋白质检测评价Bclx的作用
蛋白质表达,以及过表达转基因动物的评价。3)
双核来源的无能B细胞对Fas耐药的诱导
转基因小鼠,并监测通过体细胞拯救的自身抗体
耐药的正常动物B细胞的杂交
是在体外产生的。这项工作应该会使我们更全面地理解
B细胞对Fas介导耐药的信号和机制
细胞凋亡,并验证或驳斥上述假设,该假说具有
对血清学自身免疫发病机制的重要意义。
英文摘要
DESCRIPTION (Adapted from the Applicant's Abstract): B-cell anergy is one
mechanism utilized to expunge autoreactive immunoglobulin specificities.
Anergic B-cells survive in a state of diminished antigen receptor
responsiveness, and are deleted by Fas-mediated apoptosis induced by T
effector cells. In normal B-cells sensitivity to Fas-directed cell death
can be regulated by IL-4R and sIg signals that produce a state of
Fas-resistance. The hypothesis guiding this study is that anergic B-cells
may, as a result of specific immune signals, become resistant to
Fas-mediated apoptosis, thereby avoiding elimination and presenting the
potential for subsequent activation and autoantibody production. Elements
of this hypothesis have ramifications for B-cell immunocompetence and the
regulation of apoptosis in general. For this reason, and because so little
is known about the means by which Fas-resistance is triggered and
established, it is proposed to explore protection against Fas-directed cell
death in 3 stages. 1) Evaluate the capacity of IL-4 to oppose Fas-mediated
apoptosis by anti-Ig, and determine the role of other T-cell-derived
lymphokines, using standard cytotoxicity assays. 2) Determine the metabolic
level at which resistance to Fas-mediated apoptosis is produced by IL-4 and
by anti-Ig, by examining Fas-triggered events of protein tyrosine
phosphorylation, ceramide production, and protease activation, using Western
blotting, identification of radiolabeled lipids, and enzymatic assays of
protein digestion, and evaluate the role of Bcl-x, through tests of gene and
protein expression, and evaluation of overexpressing transgenic animals. 3)
Assess induction of Fas-resistance in anergic B-cells derived from double
transgenic mice, and monitor autoantibodies rescued through somatic cell
hybridization of B-cells from normal animals in which resistance is
generated in vitro. This work should lead to a fuller understanding of the
signals and mechanisms that produce B-cell resistance to Fas-mediated
apoptosis, and validate or refute the hypothesis described above, which has
important implications for the pathogenesis of serological autoimmunity.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
FAIM Proteostasis in ALS
-
批准号:10527540
-
项目类别:
-
资助金额:$41.53万
-
财政年份:2022
-
负责人:THOMAS L ROTHSTEIN
-
依托单位:
Human B1-like Cells and Pneumococcal Defense in the Elderly
-
批准号:10553643
-
项目类别:
-
资助金额:$37.75万
-
财政年份:2019
-
负责人:THOMAS L ROTHSTEIN
-
依托单位:
Human B1-like Cells and Pneumococcal Defense in the Elderly
-
批准号:10330573
-
项目类别:
-
资助金额:$37.75万
-
财政年份:2019
-
负责人:THOMAS L ROTHSTEIN
-
依托单位:
IgM vs IgG natural antibodies that bind pathogenic apolipoprotein B100
-
批准号:9305007
-
项目类别:
-
资助金额:$22.65万
-
财政年份:2016
-
负责人:THOMAS L ROTHSTEIN
-
依托单位:
Human B1 Lymphopoiesis
-
批准号:8385892
-
项目类别:
-
资助金额:$20.88万
-
财政年份:2012
-
负责人:THOMAS L ROTHSTEIN
-
依托单位:
Human B1 Lymphopoiesis
-
批准号:8496698
-
项目类别:
-
资助金额:$23.69万
-
财政年份:2012
-
负责人:THOMAS L ROTHSTEIN
-
依托单位:
Human B1 Cell Immunoglobulin
-
批准号:8521076
-
项目类别:
-
资助金额:$7.92万
-
财政年份:2012
-
负责人:THOMAS L ROTHSTEIN
-
依托单位:
Human B1 Cell Immunoglobulin
-
批准号:8284733
-
项目类别:
-
资助金额:$20.93万
-
财政年份:2012
-
负责人:THOMAS L ROTHSTEIN
-
依托单位:
FAIM in Immunity and Autoimmunity
-
批准号:8081080
-
项目类别:
-
资助金额:$41.09万
-
财政年份:2010
-
负责人:THOMAS L ROTHSTEIN
-
依托单位:
FAIM in Immunity and Autoimmunity
-
批准号:8489252
-
项目类别:
-
资助金额:$38.62万
-
财政年份:2010
-
负责人:THOMAS L ROTHSTEIN
-
依托单位:
FAIM in Immunity and Autoimmunity
-
批准号:7987067
-
项目类别:
-
资助金额:$41.5万
-
财政年份:2010
-
负责人:THOMAS L ROTHSTEIN
-
依托单位:
FAIM in Immunity and Autoimmunity
-
批准号:8289406
-
项目类别:
-
资助金额:$41.09万
-
财政年份:2010
-
负责人:THOMAS L ROTHSTEIN
-
依托单位:
FAIM in Immunity and Autoimmunity
-
批准号:8689885
-
项目类别:
-
资助金额:$41.09万
-
财政年份:2010
-
负责人:THOMAS L ROTHSTEIN
-
依托单位:
Aberrant Signaling in B-1 Cells
-
批准号:8282872
-
项目类别:
-
资助金额:$40.67万
-
财政年份:2009
-
负责人:THOMAS L ROTHSTEIN
-
依托单位:
Aberrant Signaling in B-1 Cells
-
批准号:7936838
-
项目类别:
-
资助金额:$41.09万
-
财政年份:2009
-
负责人:THOMAS L ROTHSTEIN
-
依托单位:
B1 Cell Induction of TH17 Cell Differentiation
-
批准号:7661078
-
项目类别:
-
资助金额:$22.41万
-
财政年份:2009
-
负责人:THOMAS L ROTHSTEIN
-
依托单位:
Aberrant Signaling in B-1 Cells
-
批准号:7582935
-
项目类别:
-
资助金额:$46.58万
-
财政年份:2009
-
负责人:THOMAS L ROTHSTEIN
-
依托单位:
B1 Cell Induction of TH17 Cell Differentiation
-
批准号:7774358
-
项目类别:
-
资助金额:$18.49万
-
财政年份:2009
-
负责人:THOMAS L ROTHSTEIN
-
依托单位:
Aberrant Signaling in B-1 Cells
-
批准号:8488386
-
项目类别:
-
资助金额:$38.23万
-
财政年份:2009
-
负责人:THOMAS L ROTHSTEIN
-
依托单位:
Aberrant Signaling in B-1 Cells
-
批准号:8099789
-
项目类别:
-
资助金额:$40.67万
-
财政年份:2009
-
负责人:THOMAS L ROTHSTEIN
-
依托单位:
海外基金